Serosurveillance Study of Maternally Derived Anti-GBS Antibody
Active, not recruitingOBSERVATIONAL
Enrollment
6,000
Participants
Timeline
Start Date
April 24, 2019
Primary Completion Date
April 30, 2021
Study Completion Date
July 30, 2025
Conditions
Group B Streptococcus Carrier in ChildbirthGroup B Streptococcal Infection, Late-OnsetGroup B Streptococcal Infection, Early-OnsetGroup B Streptococcus Neonatal SepsisGroup B Strep Infection
Trial Locations (1)
Unknown
MUJHU Care Ltd, Kampala
All Listed Sponsors
collaborator
MU-JHU CARE
OTHER
collaborator
MRC/UVRI and LSHTM Uganda Research Unit
OTHER
lead
St George's, University of London
OTHER
NCT04549220 - Serosurveillance Study of Maternally Derived Anti-GBS Antibody | Biotech Hunter | Biotech Hunter